Abstract
Purpose
Obstructive sleep apnea–hypopnea syndrome (OSAHS) is an independent risk factor for cardiovascular diseases, including hypertension. In our previous study, it was demonstrated that oral microbiota alteration in patients with OSAHS, particularly in the genera Aggregatibacter and Porphyromonas, may influence the development of hypertension. Continuous positive airway pressure (CPAP) is the main therapy for OSAHS and OSAHS-associated hypertension. However, the role of oral microbiota post CPAP treatment remains unknown.
Methods
We conducted 16S rDNA pyrosequencing and bioinformatic analyses to compare the bacterial composition of oral specimens from patients with OSAHS before and after overnight CPAP treatment.
Results
This approach enabled a relatively comprehensive description of oral microbiota, with decreases in Gemella and increases in Staphylococcus, f_Lachnospiraceae, Parabacteroides, and f_Ruminococcaceae after CPAP treatment.
Conclusion
Alteration of oral microbiota may shed new insight on the underlying pathogenesis of OSAHS-associated hypertension.
References
Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914
He QY, Feng J, Zhang XL, Liang ZA et al (2010) Sleep breath disorder group; Society of Respiratory Medicine; Chinese Medical Association. Relationship of daytime blood pressure and severity of obstructive sleep apnea among Chinese: a multi-center investigation in China. Chin Med J (Engl) 123(1):18–22
Pedrosa RP, Drager LF, Gonzaga CC et al (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817
Ko CY, Hu AK, Chou D et al (2019) Analysis of oral microbiota in patients with obstructive sleep apnea-associated hypertension. Hypertens Res 42(11):1692–1700
Zeng YM, Hu AK, Su HZ et al (2020) A review of the association between oral bacterial flora and obstructive sleep apnea-hypopnea syndrome comorbid with cardiovascular disease. Sleep Breath 24(4):1261–1266
Steier J, Jolley CJ, Seymour J et al (2009) Neural respiratory drive in obesity. Thorax 64(64):719–725
Pedrosa RP, Drager LF, de Paula LKG et al (2013) Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 144(5):1487–1494
Nural S, Günay E, Halici B et al (2013) Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36(1):66–74
Kapur VK, Auckley DH, Chowdhuri S et al (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 13(3):479–504
Patil SP, Ayappa IA, Caples SM et al (2019) Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 15(2):335–343
Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277
Wang HW, Liu HM, Zheng ZY et al (2017) Effect of the obstructive sleep apnea hypopnea syndrome treatment on blood pressure in patients with resistant hypertension. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 52(1):49–52
Tribble GD, Angelov N, Weltman R et al (2019) Frequency of tongue cleaning impacts the human tongue microbiome composition and enterosalivary circulation of nitrate. Front Cell Infect Microbiol 9:39
Eberhard J, Stumpp N, Winkel A et al (2017) Streptococcus mitis and Gemella haemolysans were simultaneously found in atherosclerotic and oral plaques of elderly without periodontitis-a pilot study. Clin Oral Investig 21(1):447–452
Torregrossa AC, Aranke M, Bryan NS (2011) Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol 8(4):230–242
Doel JJ, Benjamin N, Hector MP et al (2005) Evaluation of bacterial nitrate reduction in the human oral cavity. Eur J Oral Sci 113(1):14–19
Qu XM, Wu ZF, Pang BX et al (2016) From nitrate to nitric oxide: the role of salivary glands and oral bacteria. J Dent Res 95(13):1452–1456
Acknowledgements
We thank all the participants and their families who took part in this study.
Funding
This study was funded by the academic funding of the Second Affiliated Hospital of Fujian Medical University (grant number BS201902).
Author information
Authors and Affiliations
Contributions
Conception and design: CYK and YMZ. Acquisition of data: CYK and AKH. Analysis and interpretation of data: LXL, and LZ. Drafting or revision of the article: CYK, AKH, YMZ. Final approval of the manuscript: all authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study was approved by the second affiliated hospital of Fujian medical university’s institutional review board (IRB No. 2017–78).
Conflict of interest
The authors declare no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ko, CY., Hu, AK., Zhang, L. et al. Alterations of oral microbiota in patients with obstructive sleep apnea–hypopnea syndrome treated with continuous positive airway pressure: a pilot study. Sleep Breath 26, 811–814 (2022). https://doi.org/10.1007/s11325-021-02428-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-021-02428-7